Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Dong

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Scandinavian Journal of Rheumatology|January 1, 1994
HLA antigens in Japanese patients with systemic lupus erythematosusH Hashimoto, Y Nishimura, R P Dong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumorsK Nakagawa, T Tamura, S Negoro, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Scandinavian Journal of Rheumatology|January 1, 1994
HLA antigens in Japanese patients with systemic lupus erythematosusH Hashimoto, Y Nishimura, R P Dong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumorsK Nakagawa, T Tamura, S Negoro, et al.
Pageof 3